Number of cerebral lesions predicts freedom from new brain metastases after radiosurgery alone in lung cancer patients
- Authors:
- Dirk Rades
- Stefan Huttenlocher
- Mai Trong Khoa
- Pham Van Thai
- Dagmar Hornung
- Steven E. Schild
View Affiliations
Affiliations: Department of Radiation Oncology, University of Lübeck, Lübeck 23538, Germany, Nuclear Medicine Department, Hanoi Medical University, Hanoi 10000, Vietnam, Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi 10000, Vietnam, Department of Radiation Oncology, University Medical Center Eppendorf, Hamburg 20246, Germany, Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA
- Published online on: June 11, 2015 https://doi.org/10.3892/ol.2015.3370
-
Pages:
1109-1112
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Numerous patients with few brain metastases receive radiosurgery, either alone or in combination with whole-brain irradiation. The addition of whole-brain irradiation to radiosurgery reduces the rate of intracerebral failures, particularly the development of new cerebral lesions distant from those treated with radiosurgery. Less intracerebral failures mean less neurocognitive deficits. However, whole-brain irradiation itself may lead to a decline in neurocognitive functions. Therefore, a number of physicians have reservations with regard to adding whole-brain irradiation to radiosurgery. Prognostic factors that allow an estimation of the risk of developing new cerebral metastases can facilitate the decision regarding additional whole-brain irradiation. Since primary tumors show a different biology and clinical course, prognostic factors should be identified separately for each primary tumor leading to brain metastasis. The present study investigated 10 characteristics in a series of 98 patients receiving radiosurgery alone for 1-2 cerebral metastases from lung cancer, the most common primary tumor associated with brain metastasis. These characteristics included radiosurgery dose, age, gender, performance status, histology, number of cerebral lesions, maximum total diameter of cerebral lesions, main location of cerebral lesions, extracranial spread and interval from first diagnosis of lung cancer to administration of radiosurgery. On univariate analysis, the number of cerebral lesions prior to radiosurgery (1 vs. 2 lesions) was the only characteristic significantly associated with freedom from new brain metastases (P=0.002). In cases of 2 lesions, 73% of patients developed new cerebral lesions within 1 year. On multivariate analysis, the number of brain metastases remained significant (risk ratio, 2.46; 95% confidence interval, 1.34‑4.58; P=0.004). Given the high rates of new cerebral lesions in patients with 2 brain metastases, these patients should be strongly considered for additional whole-brain irradiation.
View References
1
|
Marvaso G, Barone A, Vaccaro C, et al:
Repeat stereotactic radiosurgery in the management of brain
metastases from NSCLC: A case report and review of the literature.
Oncol Lett. 6:897–900. 2013.PubMed/NCBI
|
2
|
Rades D, Kueter JD, Veninga T, Gliemroth J
and Schild SE: Whole brain radiotherapy plus stereotactic
radiosurgery (WBRT+SRS) versus surgery plus whole brain
radiotherapy (OP+WBRT) for 1–3 brain metastases: Results of a
matched pair analysis. Eur J Cancer. 45:400–404. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Rades D, Veninga T, Hornung D, Wittkugel
O, Schild SE and Gliemroth J: Single brain metastasis: Whole-brain
irradiation plus either radiosurgery or neurosurgical resection.
Cancer. 118:1138–1144. 2012.PubMed/NCBI
|
4
|
Aoyama H, Shirato H, Tago M, et al:
Stereotactic radiosurgery plus whole-brain radiation therapy vs
stereotactic radiosurgery alone for treatment of brain metastases:
A randomized controlled trial. JAMA. 295:2483–2491. 2006.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Rades D, Kueter JD, Hornung D, et al:
Comparison of stereotactic radiosurgery (SRS) alone and whole brain
radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to
three brain metastases. Strahlenther Onkol. 184:655–662. 2008.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Meyers CA, Smith JA, Bezjak A, et al:
Neurocognitive function and progression in patients with brain
metastases treated with whole-brain radiation and motexafin
gadolinium: Results of a randomized phase III trial. J Clin Oncol.
22:157–165. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Aoyama H, Tago M, Kato N, et al:
Neurocognitive function of patients with brain metastasis who
received either whole brain radiotherapy plus stereotactic
radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys.
68:1388–1395. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Chang EL, Wefel JS, Hess KR, et al:
Neurocognition in patients with brain metastases treated with
radiosurgery or radiosurgery plus whole-brain irradiation: A
randomised controlled trial. Lancet Oncol. 10:1037–1044. 2009.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Rice DC: The staging of lung
cancerDiagnostic Pathology of Pleuropulmonary Neoplasia. Weissferdt
A and Moran CA: Springer; New York, NY: pp. 49–51. 2013
|
10
|
Rades D, Huttenlocher S, Dahlke M, et al:
Comparison of two dose levels of stereotactic radiosurgery for 1–3
brain metastases from non-small lung cancer. Anticancer Res.
34:7309–7313. 2014.PubMed/NCBI
|
11
|
Kaplan EL and Meier P: Nonparametric
estimation from incomplete observations. J Am Stat Assoc.
53:457–481. 1958. View Article : Google Scholar
|
12
|
Liang J, Liu X, Yin B, Liu H, Xiao J and
Li Y: Efficacy assessment of pemetrexed treatment of an NSCLC case
with brain metastasis. Oncol Lett. 4:1119–1121. 2012.PubMed/NCBI
|
13
|
Lee HW, Seol HJ, Choi YL, et al: Genomic
copy number alterations associated with the early brain metastasis
of non-small cell lung cancer. Int J Oncol. 41:2013–2020.
2012.PubMed/NCBI
|
14
|
Yang G, Wang Y, Wang Y, Lin S and Sun D:
CyberKnife therapy of 24 multiple brain metastases from lung
cancer: A case report. Oncol Lett. 6:534–536. 2013.PubMed/NCBI
|